Revision: April 13, 2022, 3:26 p.m.
Rep. Merchant, Sull. 4
Rep. Guthrie, Rock. 13
Rep. M. Pearson, Rock. 34
April 5, 2022
2022-1336h
05/04
Amendment to SB 289
Amend the title of the bill by replacing it with the following:
AN ACT relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.
Amend the bill by replacing all after the enacting clause with the following:
1 Glucagon Administration. Amend the section heading of RSA 200:40-b to read as follows:
200:40-b Glucagon [Injections] Administration.
2 New Subparagraph; Controlled Drug Prescription Health and Safety Program; Dispenser Report. Amend RSA 126-A:91, VI by inserting after subparagraph (o) the following new subparagraph:
(p) The format of the prescription: electronic, faxed, written, oral, or other.
I. Section 1 of this act shall take effect 60 days after its passage.
II. The remainder of this act shall take effect upon its passage.
2022-1336h
AMENDED ANALYSIS
This bill changes a statutory reference from glucagon injections to glucagon administration. This bill also adds a requirement to the dispenser report under the controlled drug prescription health and safety program.